Local Institution

Cambridge, Cambridgeshire CB2 2XY

0 studies enrolling now · 10 studies all time

What they study most

Acute Coronary Syndrome, Advanced or Metastatic (Medically or Surgically Unresectable) Clear-cell Renal Cell Carcinoma, Atrial Fibrillation, Atrial Flutter, Carcinoma, Non-small Cell Lung, Myeloid Leukemia, Chronic, Chronic-Phase, Non-small Cell Lung Cancer, Rheumatoid Arthritis, Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus

Studies at this site

• Trial of Dasatinib in Patients With Advanced Cancers Harboring DDR2 Mutation or Inactivating B-RAF Mutation — Stopped early
• Study of Nivolumab (BMS-936558) vs. Everolimus in Pre-Treated Advanced or Metastatic Clear-cell Renal Cell Carcinoma (CheckMate 025) — Completed
• Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation — Completed
• Chronic Myelogenous Leukemia (CML) - Follow on: Study of BMS-354825 in Subjects With CML — Completed
• Phase III Acute Coronary Syndrome — Stopped early
• Methotrexate-Inadequate Response Study — Completed
• Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis — Stopped early
• Abatacept With Methotrexate- Phase IIB — Completed
• Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF Therapy — Completed
• Study of BMS-275183 in Patients With Pretreated Locally Advanced or Metastatic NSCLC (Non Small Cell Lung Cancer) — Stopped early